Tevogen Bio Holdings Statistics
Total Valuation
TVGN has a market cap or net worth of $247.70 million. The enterprise value is $248.33 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TVGN has 175.05 million shares outstanding. The number of shares has increased by 409.77% in one year.
| Current Share Class | 175.05M |
| Shares Outstanding | 175.05M |
| Shares Change (YoY) | +409.77% |
| Shares Change (QoQ) | +10.38% |
| Owned by Insiders (%) | 92.43% |
| Owned by Institutions (%) | 3.48% |
| Float | 13.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -40.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -95.06 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -542.18% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 754.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$264,515 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.29% in the last 52 weeks. The beta is -1.12, so TVGN's price volatility has been lower than the market average.
| Beta (5Y) | -1.12 |
| 52-Week Price Change | -82.29% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 4,543,916 |
Short Selling Information
The latest short interest is 2.78 million, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 2.78M |
| Short Previous Month | 1.22M |
| Short % of Shares Out | 1.59% |
| Short % of Float | 20.94% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -46.21M |
| Pretax Income | -51.21M |
| Net Income | -4.50M |
| EBITDA | -46.04M |
| EBIT | -46.21M |
| Earnings Per Share (EPS) | -$0.04 |
Full Income StatementBalance Sheet
The company has $2.33 million in cash and $2.96 million in debt, giving a net cash position of -$633,859 or -$0.00 per share.
| Cash & Cash Equivalents | 2.33M |
| Total Debt | 2.96M |
| Net Cash | -633,859 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | -6.19M |
| Book Value Per Share | -0.08 |
| Working Capital | -6.89M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.93M |
| FCF Per Share | -$0.06 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |